Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (175) Arrow Down
Filter Results: (175) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (175)
    • News  (52)
    • Research  (89)
    • Events  (2)
    • Multimedia  (3)
  • Faculty Publications  (47)

Show Results For

  • All HBS Web  (175)
    • News  (52)
    • Research  (89)
    • Events  (2)
    • Multimedia  (3)
  • Faculty Publications  (47)
← Page 2 of 175 Results →
  • 2017
  • Working Paper

Crime and Violence: Desensitization in Victims to Watching Criminal Events

By: Rafael Di Tella, Lucia Freira, Ramiro H. Gálvez, Ernesto Schargrodsky, Diego Shalom and Mariano Sigman
We study desensitization to crime in a lab experiment by showing footage of criminal acts to a group of subjects, some of whom have been previously victimized. We measure biological markers of stress and behavioral indices of cognitive control before and after treated... View Details
Keywords: Crime and Corruption; Attitudes; Perspective; Behavior
Citation
Find at Harvard
Read Now
Related
Di Tella, Rafael, Lucia Freira, Ramiro H. Gálvez, Ernesto Schargrodsky, Diego Shalom, and Mariano Sigman. "Crime and Violence: Desensitization in Victims to Watching Criminal Events." NBER Working Paper Series, No. 23697, August 2017.
  • 11 Oct 2017
  • Working Paper Summaries

Crime and Violence: Desensitization in Victims to Watching Criminal Events

Keywords: by Rafael Di Tella, Lucia Freira, Ramiro H. Gálvez, Ernesto Schargrodsky, Diego Shalom, and Mariano Sigman
  • 2009
  • Article

Synthesis by Microbes or Chemists? Pharmaceutical Research and Manufacturing in the Antibiotic Era

By: Arthur A. Daemmrich
This article presents a case study of the rise of Pfizer as a leading pharmaceutical company, with a focus on changing relationships between manufacturing technology and R&D between the mid-1940s and the mid-1960s. Pfizer first moved into pharmaceuticals through... View Details
Keywords: Research and Development; Production; Technology; Transformation; Relationships; Success; Organizations; Programs; Chemicals; Alignment; Pharmaceutical Industry; United States
Citation
Find at Harvard
Related
Daemmrich, Arthur A. "Synthesis by Microbes or Chemists? Pharmaceutical Research and Manufacturing in the Antibiotic Era." History and Technology 23, no. 3 (2009): 237–256.
  • May 2007 (Revised September 2008)
  • Case

Biocon Limited

By: Krishna G. Palepu and Ananth Chepuri
Biocon Limited was facing significant pricing pressure in their cash cow business, that primarily consisted of manufacturing Active Pharmaceutical Ingredients (APIs). To combat this commoditization, Biocon's leadership had chosen an innovation-led strategy. This new... View Details
Keywords: Globalized Firms and Management; Innovation and Management; Leading Change; Growth and Development Strategy; Risk Management; Organizational Change and Adaptation; Biotechnology Industry; India
Citation
Educators
Purchase
Related
Palepu, Krishna G., and Ananth Chepuri. "Biocon Limited." Harvard Business School Case 107-083, May 2007. (Revised September 2008.)
  • February 2005
  • Article

Managing the Ecosystem

By: Marco Iansiti
The days of the corporate lone wolf are over. In our increasingly interconnected world, standing alone is no longer a viable business model. Instead, smart companies rely heavily on networks of partners, suppliers, and customers to achieve market success and sustain... View Details
Keywords: Integrated Corporate Reporting; Partners and Partnerships; Industry Clusters; Customers; Markets; Situation or Environment; Banks and Banking; Insurance; Software
Citation
Find at Harvard
Related
Iansiti, Marco. "Managing the Ecosystem." Optimize 4, no. 2 (February 2005).
  • 15 Jul 2020
  • News

The Good Side of Bad Feelings

  • 12 Jul 2016
  • First Look

July 12, 2016

spending. Whereas traditional (small-molecule) drugs have historically faced price competition from generic drugs after patent expiration, biosimilars—biologic drugs that have been shown to be therapeutically equivalent to an already approved View Details
Keywords: Sean Silverthorne
  • Article

Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users

By: Ariel Dora Stern, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup and Ernst R. Berndt
Biologic drugs account for a disproportionate share of the increase in pharmaceutical spending in the U.S. and worldwide. Against this backdrop, many look to the expanding market for biosimilars—follow-on products to biologic drugs—as a vehicle for controlling... View Details
Keywords: Pharmaceuticals; Drug Spending; Drug Pricing; Health Care and Treatment; Spending; Price; Markets; Cost Management; United States
Citation
Find at Harvard
Read Now
Purchase
Related
Stern, Ariel Dora, Jacqueline L. Chen, Melissa Ouellet, Mark R. Trusheim, Zeid El-Kilani, Amber Jessup, and Ernst R. Berndt. "Biosimilars and Follow-On Products in the United States: Adoption, Prices, and Users." Health Affairs 40, no. 6 (June 2021): 989–999.
  • Research Summary

Risk, Trust and Escalation Behavior of Owner Managers

By: Cynthia A. Montgomery
Professor Montgomery and Professor Deepak Malhotra (HBS), together with scientists from Harvard's Program on Evolutionary Dynamics, are studying risk-related decision making of owner managers in newly-founded and established companies.  This experimental... View Details
  • May 2016
  • Case

AbbVie

By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher
This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details
Keywords: Pharmaceutical Company; M&A Valuation; AbbVie; Health Care; Health Care and Treatment; Pharmaceutical Industry; Health Industry; United States
Citation
Educators
Purchase
Related
Schulman, Kevin, Laura Little, Samyukta Mullangi, and Stephen Schleicher. "AbbVie." Harvard Business School Case 316-095, May 2016.
  • 14 Apr 2010
  • News

Straight Talk: Oprah's Leadership Lessons

  • 15 Jun 2021
  • News

Podcast: How Biosimilars Are Affecting the Drug Markets

  • March 2018 (Revised March 2019)
  • Case

Gender and Free Speech at Google (A)

By: Nien-hê Hsieh, Martha J. Crawford and Sarah Mehta
In August 2017, Google fired James Damore, a 28-year-old software engineer who had been employed by the company since 2013. The move came after Damore penned an internal company memo titled “Google’s Ideological Echo Chamber,” which posited that innate biological... View Details
Keywords: Free Speech; Representation; Diversity; Gender; Race; Human Resources; Employees; Employee Relationship Management; Recruitment; Selection and Staffing; Labor; Employment; Lawsuits and Litigation; Organizational Culture; Technology Industry; United States; California
Citation
Educators
Purchase
Related
Hsieh, Nien-hê, Martha J. Crawford, and Sarah Mehta. "Gender and Free Speech at Google (A)." Harvard Business School Case 318-085, March 2018. (Revised March 2019.)
  • June 2016 (Revised August 2019)
  • Case

Numenta: Inventing and (or) Commercializing AI

By: David B. Yoffie, Liz Kind and David Ben Shimol
In March 2016, Donna Dubinsky (co-founder and CEO) and Jeff Hawkins (co-founder) were struggling with a key question: Could Numenta be successful in both creating fundamental technology and building a commercial business? Located in Redwood City, CA, Numenta was... View Details
Keywords: Artificial Intelligence; Machine Intelligence; Machine Learning; Strategy; Business Model; Entrepreneurship; Information; Technological Innovation; Research; Research and Development; Information Technology; Applications and Software; Technology Adoption; Digital Platforms; Commercialization; AI and Machine Learning
Citation
Educators
Purchase
Related
Yoffie, David B., Liz Kind, and David Ben Shimol. "Numenta: Inventing and (or) Commercializing AI." Harvard Business School Case 716-469, June 2016. (Revised August 2019.)
  • Article

Matriarch: A Python Library for Materials Architecture

By: Tristan Giesa, Ravi Jagadeesan, David I. Spivak and Markus J. Buehler
Biological materials, such as proteins, often have a hierarchical structure ranging from basic building blocks at the nanoscale (e.g., amino acids) to assembled structures at the macroscale (e.g., fibers). Current software for materials engineering allows the user to... View Details
Keywords: Building Block; Category Theory; Hierarchical Protein Materials; Molecular Design; Open-Source Software; Structure Creation
Citation
Find at Harvard
Purchase
Related
Giesa, Tristan, Ravi Jagadeesan, David I. Spivak, and Markus J. Buehler. "Matriarch: A Python Library for Materials Architecture." ACS Biomaterials Science & Engineering 1, no. 10 (October 2015): 1009–1015.
  • Research Summary

Understanding Human Nature

By: Nitin Nohria
Recent advances in biological sciences provide great insights into the workings of the human brain and thereby into human nature. Drawing upon this research, my colleague Paul Lawrence and I propose a neo-Darwinian theory of human motivation based on four basic human... View Details
  • 07 Mar 2019
  • HBS Seminar

Petra Moser, NYU Stern School of Business

  • 2009
  • Case

The Prediction Lover's Handbook

By: Thomas H. Davenport and Jeanne G. Harris
When picking assessment tools to inform better decisions about future paths, executives are faced with a wide variety of options--some of which are well established, while others are in early stages of development. The authors provide an insider's guide to prediction... View Details
Keywords: Analytics; Analysis; Forecasting and Prediction
Citation
Purchase
Related
Davenport, Thomas H., and Jeanne G. Harris. "The Prediction Lover's Handbook." 2009.
  • October 2022
  • Case

Afrigen Biologics: Vaccines for the Global South

By: Debora L. Spar and Julia Comeau
The majority of vaccines used on the continent of Africa (99%) are produced offshore. This makes African nations reliant on the West for major health care needs, a problem which was exacerbated by the COVID-19 pandemic. Afrigen Biologics (in partnership with the WHO)... View Details
Keywords: Vaccination; Vaccine; mRNA; COVID; COVID-19; Inequity; Hub-and-spoke; Health Care and Treatment; Health Pandemics; Production; Social Issues; Business and Government Relations; South Africa; Africa
Citation
Educators
Purchase
Related
Spar, Debora L., and Julia Comeau. "Afrigen Biologics: Vaccines for the Global South." Harvard Business School Case 323-030, October 2022.
  • 18 Apr 2018
  • News

What Most People Get Wrong About Men and Women

  • ←
  • 2
  • 3
  • …
  • 8
  • 9
  • →
ǁ
Campus Map
Harvard Business School
Soldiers Field
Boston, MA 02163
→Map & Directions
→More Contact Information
  • Make a Gift
  • Site Map
  • Jobs
  • Harvard University
  • Trademarks
  • Policies
  • Accessibility
  • Digital Accessibility
Copyright © President & Fellows of Harvard College.